Detalhe da pesquisa
1.
Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML.
Blood
; 129(12): 1636-1645, 2017 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28049642
2.
Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial.
Blood Adv
; 5(4): 1110-1121, 2021 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33616652
3.
Graft-Versus-Leukemia Effect of Allogeneic Stem-Cell Transplantation and Minimal Residual Disease in Patients With Acute Myeloid Leukemia in First Complete Remission.
JCO Precis Oncol
; 1: 1-13, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35172507
4.
Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junction.
Cancer Chemother Pharmacol
; 76(6): 1285-95, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26499900
5.
[Patients with a haematological malignancy in intensive care]. / Patiënten met een hematologische maligniteit op de Intensive Care.
Ned Tijdschr Geneeskd
; 153: A582, 2009.
Artigo
em Holandês
| MEDLINE | ID: mdl-19930742